NASDAQ : SNWV

SANUWAVE Health, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 5.15 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 44.30M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

SANUWAVE Health, Inc. (SNWV) reported revenue of 44.02M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue44.02M44.05M32.63M20.40M16.74M13.01M
Revenue44.02M44.05M32.63M20.40M16.74M13.01M
Cost of Revenue10.42M10.08M8.08M6.04M4.33M4.99M
Gross Profit33.60M33.97M24.55M14.36M12.41M8.02M
Selling, General & Admin27.28M25.22M17.67M13.57M20.03M20.28M
Research & Development2.24M1.35M673.00K579.00K567.00K1.10M
Operating Expenses30.53M27.46M19.13M14.90M21.36M22.17M
Operating Income3.07M6.51M5.42M-540.00K-8.95M-14.14M
Interest Expense-3.46M-6.25M-13.78M-15.62M-14.13M-7.09M
Currency Exchange Gain (Loss)-4.00K
Other Non Operating Income (Expenses)12.76M8.87M-31.95M-9.64M16.64M-2.62M
EBT Excluding Unusual Items12.37M9.14M-40.31M-25.80M-6.44M-23.86M
Asset Writedown-196.00K-196.00K
Other Unusual Items3.18M2.96M7.26M-3.85M-3.37M
Pretax Income15.35M11.90M-33.06M-25.80M-10.29M-27.23M
Income Tax Expense92.00K86.00K27.00K4.00K2.00K28.00K
Net Income15.26M11.81M-33.08M-25.81M-10.29M-27.26M
Net Income to Common15.26M11.81M-33.08M-25.81M-10.29M-27.26M
Shares Outstanding (Basic)8.58M8.56M4.46M2.12M1.47M1.38M
Shares Outstanding (Diluted)9.10M9.08M4.46M2.12M1.47M1.38M
EPS (Basic)1.781.38-7.41-12.19-7.02-19.72
EPS (Diluted)0.780.41-7.41-12.19-7.50-19.72
Free Cash Flow4.21M1.93M1.97M-4.54M-17.17M-6.94M
Free Cash Flow Per Share0.460.210.44-2.14-11.72-5.02
Gross Margin76.33%77.11%75.23%70.41%74.13%61.68%
Operating Margin6.97%14.78%16.60%-2.65%-53.47%-108.70%
Profit Margin34.66%26.82%-101.38%-126.52%-61.48%-209.52%
Free Cash Flow Margin9.56%4.39%6.02%-22.25%-102.55%-53.33%
EBITDA4.26M7.49M6.21M488.00K-8.00M-12.91M
EBITDA Margin9.68%16.99%19.01%2.39%-47.78%-99.20%
D&A For EBITDA1.19M974.00K788.00K1.03M952.00K1.24M
EBIT3.07M6.51M5.42M-540.00K-8.95M-14.14M
EBIT Margin6.97%14.78%16.60%-2.65%-53.47%-108.70%
Effective Tax Rate0.60%0.72%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents9.38M11.96M10.24M1.80M1.15M619.00K
Cash & Short-Term Investments9.38M11.96M10.24M1.80M1.15M619.00K
Receivables5.80M5.42M3.33M3.31M4.03M2.42M
Inventory7.07M5.93M4.15M2.95M868.00K1.04M
Prepaid Expenses954.00K1.31M682.00K1.72M570.00K326.00K
Total Current Assets23.20M24.63M18.40M9.78M6.62M4.40M
Property, Plant & Equipment3.21M2.36M732.00K938.00K856.00K1.01M
Goodwill7.26M7.26M7.26M7.26M7.26M7.26M
Other Intangible Assets2.89M3.03M3.73M4.43M5.14M5.84M
Long-Term Deferred Charges49.00K68.00K
Other Long-Term Assets106.00K
Total Assets36.60M37.34M30.12M22.42M19.87M18.62M
Accounts Payable3.31M3.25M3.73M5.71M4.40M7.64M
Accrued Expenses6.87M6.25M5.79M10.53M11.77M9.50M
Short-Term Debt25.30M31.45M40.67M26.97M
Current Portion of Long-Term Debt5.60M5.64M158.00K
Current Portion of Leases5.00K157.00K301.00K
Current Unearned Revenue632.00K388.00K193.00K92.00K60.00K48.00K
Other Current Liabilities1.76M2.16M10.10M16.98M3.32M11.95M
Total Current Liabilities18.17M17.85M45.42M64.75M60.22M56.26M
Long-Term Debt13.58M16.32M875.00K
Long-Term Leases1.52M854.00K191.00K492.00K438.00K118.00K
Long-Term Unearned Revenue543.00K701.00K300.00K347.00K230.00K293.00K
Long-Term Deferred Tax Liabilities28.00K
Total Liabilities33.82M35.72M45.91M65.59M60.88M57.58M
Common Stock9.00K9.00K9.00K3.00K549.00K482.00K
Additional Paid-In Capital247.57M244.28M238.69M176.98M152.75M144.58M
Retained Earnings-244.81M-242.69M-254.50M-220.05M-194.24M-183.95M
Comprehensive Income & Other10.00K10.00K10.00K-111.00K-67.00K-73.00K
Shareholders' Equity2.79M1.62M-15.79M-43.18M-41.01M-38.96M
Total Liabilities & Equity36.60M37.34M30.12M22.42M19.87M18.62M
Total Debt20.71M22.97M25.80M31.94M41.11M28.12M
Net Cash (Debt)-11.33M-11.01M-15.56M-30.15M-39.95M-27.50M
Net Cash Per Share-1.24-1.21-3.49-14.24-27.27-19.89
Filing Date Shares Outstanding8.60M8.59M8.55M3.04M1.46M1.38M
Total Common Shares Outstanding8.60M8.59M8.54M3.04M1.46M1.28M
Working Capital5.03M6.78M-27.03M-54.97M-53.59M-51.86M
Book Value Per Share0.320.19-1.85-14.20-28.03-30.33
Tangible Book Value-7.36M-8.67M-26.79M-54.87M-53.41M-52.06M
Tangible Book Value Per Share-0.86-1.01-3.14-18.04-36.50-40.53
Machinery1.31M732.00K
Leasehold Improvements1.02M31.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income15.26M11.81M-33.08M-25.81M-10.29M-27.26M
Depreciation & Amortization1.37M1.28M1.15M1.03M952.00K1.24M
Other Amortization510.00K1.46M5.52M6.91M4.95M3.23M
Loss (Gain) From Sale of Assets-5.15M-5.17M
Stock-Based Compensation5.89M4.85M1.51M224.00K888.00K
Provision & Write-off of Bad Debts450.00K202.00K77.00K781.00K253.00K442.00K
Other Operating Activities-10.82M-6.55M28.47M15.93M-12.80M6.02M
Change in Accounts Receivable-2.40M-2.30M-486.00K-53.00K-1.75M-395.00K
Change in Inventory-1.73M-2.28M-1.20M-2.80M-72.00K1.69M
Change in Accounts Payable-928.00K-521.00K-1.42M1.55M-2.55M3.18M
Change in Other Net Operating Assets2.77M1.08M1.91M-2.30M3.25M5.46M
Operating Cash Flow5.22M3.88M2.46M-4.54M-17.17M-6.41M
Capital Expenditures-1.01M-1.94M-490.00K-529.00K
Sale of Property, Plant & Equipment5.38M5.38M21.00K332.00K
Investing Cash Flow4.15M3.43M-490.00K21.00K332.00K-529.00K
Short-Term Debt Issued1.80M6.02M17.56M1.91M
Long-Term Debt Issued23.66M2.94M3.90M
Total Debt Issued23.66M23.66M1.80M6.02M20.50M5.81M
Short-Term Debt Repaid-27.75M-5.54M-639.00K-2.98M-493.00K
Long-Term Debt Repaid-1.68M-208.00K-170.00K-237.00K-199.00K
Total Debt Repaid-32.15M-29.43M-5.75M-809.00K-3.22M-692.00K
Net Debt Issued (Repaid)-8.50M-5.77M-3.95M5.21M17.28M5.12M
Issuance of Common Stock380.00K556.00K10.30M100.00K
Other Financing Activities-371.00K-371.00K
Financing Cash Flow-8.49M-5.59M6.35M5.21M17.38M5.12M
Foreign Exchange Rate Adjustments121.00K-50.00K-13.00K-1.00K
Net Cash Flow880.00K1.72M8.44M644.00K534.00K-1.82M
Free Cash Flow4.21M1.93M1.97M-4.54M-17.17M-6.94M
Free Cash Flow Margin9.56%4.39%6.02%-22.25%-102.55%-53.33%
Free Cash Flow Per Share0.460.210.44-2.14-11.72-5.02
Levered Free Cash Flow-2.83M-6.45M-11.20M9.30M-18.92M2.38M
Unlevered Free Cash Flow-1.17M-4.01M-8.10M12.15M-15.03M3.59M
Cash Interest Paid2.32M3.74M4.31M1.96M3.71M2.58M
Cash Income Tax Paid78.00K27.00K4.00K
Change in Working Capital-2.29M-4.01M-1.19M-3.61M-1.12M9.93M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization49.81M255.91M196.29M14.83M12.51M81.88M
Enterprise Value61.14M270.76M227.78M53.46M45.23M100.51M
Last Close Price5.1529.8423.004.878.5563.75
PE Ratio7.4121.66
Forward PE38.26
PS Ratio1.015.816.010.730.756.29
PB Ratio15.90158.07-12.43-0.34-0.30-2.10
P/FCF Ratio10.53132.3299.89
P/OCF Ratio8.4866.0379.95
EV/Sales Ratio1.266.156.982.622.707.72
EV/EBITDA Ratio13.0536.1736.71109.55
EV/EBIT Ratio18.1341.5842.05
EV/FCF Ratio13.22140.00115.92
Debt / Equity Ratio7.4314.19-1.63-0.74-1.00-0.72
Debt / EBITDA Ratio4.663.024.1665.46
Debt / FCF Ratio4.9211.8813.13
Net Debt / Equity Ratio4.076.80-0.98-0.70-0.97-0.71
Net Debt / EBITDA Ratio2.661.472.5161.78-4.99-2.13
Net Debt / FCF Ratio2.695.697.92-6.64-2.33-3.96
Asset Turnover1.261.311.240.960.870.62
Inventory Turnover1.602.002.283.164.542.50
Quick Ratio0.830.970.300.080.090.05
Current Ratio1.281.380.410.150.110.08
Return on Assets (ROA)5.51%12.07%12.89%-1.60%-29.07%-42.45%
Return on Invested Capital (ROIC)22.32%
Return on Capital Employed (ROCE)16.70%33.40%-35.40%1.30%22.20%37.60%
Earnings Yield13.50%4.62%-16.86%-174.05%-82.27%-33.29%
FCF Yield9.50%0.76%1.00%-30.61%-137.23%-8.47%
Buyback Yield / Dilution-26.83%-103.51%-110.82%-44.47%-6.00%-37.08%